Drugs / HYP-2090PTSA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06243354 | Feb 2024 → Dec 2026 expected | — | Sichuan Huiyu Pharmaceutical Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HYP-2090PTSA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06243354 ↗ |
| Route | Oral | “Take orally on an empty stomach.” NCT06243354 ↗ |